Ampersand Capital Partners is a middle market private equity firm based in Massachusetts, established in 1988. The firm focuses on making investments primarily in two sectors: healthcare and industrial. With a commitment to identifying and supporting growth opportunities, Ampersand seeks to partner with companies that have the potential for significant development within these industries. Through its strategic investments, the firm aims to enhance the operational capabilities and market positions of its portfolio companies.
AnaBios specializes in enabling human-focused drug discovery. As a CRO, AnaBios provides products and services for every stage of drug discovery. Through proprietary technology based on the use of human donor organs and tissues, it studies ex vivo human responses to drugs and further investigate the molecular and functional basis of relevant human physiology. Its research focuses primarily on the areas of high, unmet medical need, including cardiac disease and safety, pain, PKD kidney disease, and neurodegeneration.
In partnership with Fortune 500 pharmaceutical companies, contract research organizations, and universities, the company's mission is to develop therapeutic advancements to help patients live longer, healthier, and more productive lives.
Vernal Biosciences
Venture Round in 2022
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Syft Technologies Ltd. develops, markets, and supports air analysis solutions for research teams, commercial laboratories, government agencies, and private companies. The company offers Voice200 SIFT-MS instruments that allow users to identify and measure a range of compounds simultaneously; Sample Collection Case that combines sample collection hardware into one compact and portable package; and Sample Bag Flushing Station that simultaneously cleans sample bags. Its analytical solutions are used in container air analysis; food, flavor, and fragrance; medical research; environmental; and oil and gas exploration market sectors. The company offers its products through a network of distributors in Benelux, Germany, Austria, Switzerland, Italy, and France. Syft Technologies Ltd. was founded in 2002 and is based in Christchurch, New Zealand. The company has locations in Christchurch, New Zealand; Warrington, the United Kingdom; and Pittsburgh, Pennsylvania.
BioEcho Life Sciences develop and produce next-generation technologies and products to enable molecular biology and diagnostics laboratory workflows of higher convenience, higher robustness, and higher sustainability.
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.
Genezen Laboratories is focused on supporting the demands of the current and future gene and cell therapy manufacturing market-making viral vector production accessible to both early-stage, growth-oriented companies, and well-established industry leaders. The Genezen mission of gene and cell therapy acceleration is the outcome of expansive knowledge and experience in the industry and working with the nation’s leading institutions. Our developed solutions provide the right expertise, capacity, and technology to bring breakthrough treatments to market.
American Laboratory Products offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.
GeneWerk GmbH is a laboratory based in Heidelberg, Germany, specializing in testing for cell and gene therapies. Founded in July 2014 by a team of experts, including Prof. Dr. Christof von Kalle, Dr. Manfred Schmidt, and Dr. Annette Deichmann, the company offers a range of services for preclinical and clinical trial patient sample analysis. Its product offerings include integration site analysis of viral vectors using various techniques, quality control for AAV vectors, immune repertoire analysis, and gene editing analyses. Additionally, GeneWerk provides qPCR services and develops bioinformatics solutions utilizing next-generation sequencing technologies. The company leverages its extensive experience in integration site analysis and high-throughput sequencing to innovate and enhance analytical methods for diverse projects.
Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.
New England Peptide, Inc. specializes in the design and manufacture of various peptide-related products. The company offers a range of bioactive peptides, amino acids, phospho amino acids, pseudoprolines, and heavy amino acids, along with peptide synthesis accessories. Additionally, it provides stable isotope standard tryptic peptides for protein identification and quantification, exosome isolation products, and both custom polyclonal and monoclonal antibodies. New England Peptide also offers analytical services that include amino acid analysis, liquid chromatography/mass spectrometry, sequencing, and sample preparation. The company primarily serves organizations involved in drug and vaccine discovery and distributes its products online and through partners in Japan, Taiwan, and Korea. Founded in 1998 and headquartered in Harvard, Massachusetts, with an additional office in Cambridge, New England Peptide continues to focus on quality and customer service in the peptide industry.
Vibalogics is a contract development and manufacturing organization focused on complex live biological products. Vibalogics offers process development, manufacturing and fill & finish of products for biopharmaceutical companies involved in the development of oncolytic viral therapies, gene therapies, and vaccines.
GenDx develops and markets a comprehensive line of In Vitro Diagnostic (IVD) tests and services, analysis software and education. The company is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation offering high resolution HLA typing methods for Sanger and NGS techniques.
Canopy Biosciences is a biotechnology company based in St. Louis, Missouri, founded in 2016. It specializes in providing research tools and services for genetic engineering and personalized medicine. The company's gene editing technology, known as TUNR, works by targeting translation elongation to insert polyA tracks into specific coding regions of the genome. This process effectively reduces the levels of mRNA transcribed from the gene, leading to a suppression of protein expression. The technology was initially developed by Professors Sergej Djuranovic and Rachel Green at Washington University School of Medicine and Johns Hopkins University, respectively. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.
MedPharm Ltd. specializes in providing research and development services for topical and transdermal pharmaceutical products, including those for dermatological, nail, eye, airway, and mucosal membrane applications. The company employs advanced drug delivery technologies, such as MedSpray, which enables aerosol-based delivery of medications to various membranes. MedPharm offers a comprehensive range of services, including target product profiling, API characterization, bio-analysis, formulation optimization, efficacy and toxicity testing, and the manufacturing of clinical supplies. The firm also focuses on development strategies that consider optimal dosage forms, patient compliance, and regulatory requirements. Its analytical services encompass physical and chemical stability assessments, as well as various characterization techniques. With a global customer base spanning the United States, Europe, Australia, Japan, India, South Korea, the Middle East, and China, MedPharm has established itself as a leading contract provider in its field since its founding in 1999, with headquarters in Guildford, United Kingdom, and an additional office in Durham, North Carolina.
Nexcelom Bioscience LLC, a biotechnology company, develops and markets image cytometry products for cell analysis in life science and biomedical research. It offers Cellometer, helps to count and analyze cell lines and primary cells, through bright field and fluorescence imaging modes; and Celigo, which provides high image quality, high throughput image cytometry system for adherent and suspension cells in microwell plates. Additionally, the company also offers fluorescent reagents and kits for cell counting and cell-based assays. The company provides its products for life science industry. The company was incorporated in 2003 and is based in Lawrence, Massachusetts.
Detector Technology, Inc. is a world-class leading manufacturer of products and systems for OEM and equipment manufacturers. DeTech specializes in Channel Electron Multipliers, Glass Extrusion & Fabrication and Motion Control Products. With a state of the art fabrication and production facility, our dedicated team has been delivering excellence in manufacturing and customer satisfaction over the last 20 years.
LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. The company's range of services covering areas such as antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing and bioanalytics focus on integrated platforms to support projects throughout the drug discovery process and offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal enabling clients to accelerate product development from lead discovery to Phase 1 clinical trials. Located in the heart of the San Francisco Bay Area, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to its customers. The production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director to ensure timely completion with superior results and transparent communication. Clients have real-time access to their project data and can view and receive status updates through LakePharma’s secure cloud-based Datasystems. LakePharma follows the principles of Good Laboratory Practices (GLP) to ensure the quality, reliability and integrity of study data. Upon request, services can also be performed in full compliance with FDA documentation requirements for submissions for nonclinical laboratory studies. All services are provided solely on a fee-for-service basis and are royalty-free.
CORPUS MEDICAL INC. provides top-notch consulting services for the medical device industry. We have extensive experience in developing a wide array of medical devices, we work fast and smart and we are passionate about what we do. From concept to market, let us be your partner.
Canopy Biosciences is a biotechnology company based in St. Louis, Missouri, founded in 2016. It specializes in providing research tools and services for genetic engineering and personalized medicine. The company's gene editing technology, known as TUNR, works by targeting translation elongation to insert polyA tracks into specific coding regions of the genome. This process effectively reduces the levels of mRNA transcribed from the gene, leading to a suppression of protein expression. The technology was initially developed by Professors Sergej Djuranovic and Rachel Green at Washington University School of Medicine and Johns Hopkins University, respectively. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Brammer Bio, LLC specializes in developing and manufacturing cell and gene therapies for the pharmaceutical and biotechnology sectors. The company provides a range of services, including pre-clinical process and analytical development, process optimization, scale-up, and clinical and commercial supply of drug substances and formulated products. With a focus on autologous and allogeneic cell therapies, as well as viral vector products for therapeutic applications, Brammer Bio supports biopharma clients in accelerating the delivery of innovative medicines. The company operates a 45,000 square foot facility in Alachua, Florida, and is expanding with a new 50,000 square foot facility in Lexington, Massachusetts, which will feature large-scale manufacturing suites and laboratories for both clinical and commercial purposes. Established in 2013 and formerly known as Brammer Biopharmaceuticals, Brammer Bio became a subsidiary of Thermo Fisher Scientific in 2019.
Avista Pharma Solutions is a contract testing, development and manufacturing organization encompassing over 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, MA, Durham, NC, and Longmont, CO), providing pharmaceutical, animal health and medical device clients with a broad suite of scientifically-differentiated services ranging from early drug development to drug product manufacturing.
Protein Technologies supply quality peptide synthesizers and reagents to universities, biotechnology companies, pharmaceutical companies and peptide houses.
GENEWIZ is a leading global genomics service company. A full-service provider, GENEWIZ provides DNA sequencing, gene synthesis, molecular biology, next generation sequencing, bioinformatics, and GLP regulatory services.
From the company’s founding, GENEWIZ has maintained its unwavering commitment to providing customers with the best value. Excelling in both science and customer support, GENEWIZ is dedicated to accelerating scientific discovery, as well as to developing and delivering innovative solutions for translational medicine and healthcare. Easily accessible around the world, GENEWIZ is the preferred partner at leading academic, pharmaceutical, biotechnology, agricultural, government, and clinical institutions.
At GENEWIZ, it is their mission to contribute to the advancement of life sciences and technologies. Together with their clients, they can make a difference in the pursuit of scientific discoveries, better healthcare, a greener environment, and abundant food supplies. Their goal is to be the best in the world and the best for the world.
Headquartered in South Plainfield, NJ, GENEWIZ is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; Los Angeles, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; Langen, Germany; and Tokyo, Japan.
Azurity Pharmaceuticals is a developer of drug products and technologies to address the needs of patients. Its drug products such as antimicrobial, mouthwashes, and testosterone enable pharmacists to prepare drugs for those populations who are in need of a better alternative to traditionally-compounded medications.
Elite One Source Nutritional Services, Inc together with its subsidiary provides contract manufacturing services for nutritional and dietary supplements. The company was incorporated in 2013 and is based in Missoula, Montana. As of February 7, 2018, Elite One Source Nutritional Services, Inc operates as a subsidiary of DCC Health & Beauty Solutions Limited.
Nutramed, Inc. develops, manufactures, and markets tablet, capsule, and powder nutritional supplement products for customers in the United States and internationally. It offers a range of manufacturing services, including blending, granulation, tableting, timed release formulation, bilayer tablets, various types of tablet coatings, two-piece hard-shell encapsulation, stick-packs, multi-packs, blister cards, pack out, powder packaging, and tablet and capsule packaging. The company also offers enteric coating on tablets, capsules, and soft gels. The company was founded in 1998 and is headquartered in Chino, California
Sanova Dermatology, PLLC offers cosmetic dermatology services. The company offers treatments for wrinkle reduction, acne, moles, and skin cancer. The company is headquartered in Austin, Texas.
Bioventus LLC develops and/or markets orthobiologic solutions for bone fusion and osteoarthritis. Its active healing therapies product line supports accelerated and more complete healing of bone fractures, and treats the chronic pain associated with osteoarthritis; and bone healing solutions work to enhance the body’s natural healing process. The company also provides injection therapies that treat osteoarthritic joints relieve pain and help bring mobility back to the patient; and surgical orthobiologics. Its products are available through a network of distributors. The company was incorporated in 2011 and is based in Durham, North Carolina. Bioventus LLC operates as a subsidiary of Bioventus Inc.
Bioventus LLC develops and/or markets orthobiologic solutions for bone fusion and osteoarthritis. Its active healing therapies product line supports accelerated and more complete healing of bone fractures, and treats the chronic pain associated with osteoarthritis; and bone healing solutions work to enhance the body’s natural healing process. The company also provides injection therapies that treat osteoarthritic joints relieve pain and help bring mobility back to the patient; and surgical orthobiologics. Its products are available through a network of distributors. The company was incorporated in 2011 and is based in Durham, North Carolina. Bioventus LLC operates as a subsidiary of Bioventus Inc.
NDC is a privately held medical device company headquartered in Fremont, CA, USA. Focused on the medical field, NDC provides manufacturing, research, development, regulatory and technical support on all aspects of Nitinol technology and processing, and is aggressively expanding its capabilities to meet the growing demand for its shape-memory and superelastic Nitinol products.
Blue Sky Biotech, Inc. is a Contract Research Organization (CRO) in the pharmaceutical R&D market. As a trusted partner to nine of Fortune’s Top 10 Pharmaceutical Companies, Blue Sky has a proven track record with industry leaders. Blue Sky aims to alleviate the onerous and labor-intensive tasks that take scientists away from key experimentation, novel theory exploration and other optimal uses of their time. Blue Sky is synonymous with productivity in the early discovery biology processes known as genetic cloning, recombinant protein expression and laboratory-scale fermentation (scale-up bioprocessing). We are motivated by our ability to impact the overall efficiency of the drug discovery process, thus contributing to a longer, healthier lifespan for human beings.
FirstRain, Inc. develops a business analytics platform that assists Fortune 1000 companies in building their strategies, creating lead generation campaigns, discovering and developing new sales opportunities, and identifying business risks. The company was founded in 2000 and is headquartered in San Mateo, California. As of July 31, 2017, FirstRain, Inc. operates as a subsidiary of Ignite Technologies, Inc.
Bako Integrated Physician Solutions is the premier provider of diagnostic and therapeutic services focusing on the skin, soft tissue and bone of the lower extremity. Their pathology team provides not just information, but also intelligence to enable better patient care.
FirstRain, Inc. develops a business analytics platform that assists Fortune 1000 companies in building their strategies, creating lead generation campaigns, discovering and developing new sales opportunities, and identifying business risks. The company was founded in 2000 and is headquartered in San Mateo, California. As of July 31, 2017, FirstRain, Inc. operates as a subsidiary of Ignite Technologies, Inc.
Agilux Laboratories is a contract research organization. The company offers a range of services supporting discovery, pre-clinical, and clinical services. It provides a range of drug metabolism and pharmacokinetic services for biotech and pharmaceutical industries. The company’s services include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and Immunoassays services.
It focuses on bioanalytical and PK/PD testing services for the biotech and pharmaceutical industries. Agilux Laboratories was founded by Peter Glick in 2007 and is headquartered in Worcester, Massachusetts.
RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.
ChanTest has developed the world's most complete library of validated human ion channel-expressing cell lines to serve all the ion channel needs of its pharmaceutical and biotech customers. Services range from early functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process – to a complete set of in vitro GLP service products for cardiac risk assessment. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately – to help make better, safer drugs.
An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases – from inflammatory diseases to cancer – based on the company's proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent's first products, now in pre-clinical development, are drug candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful tkRNAi technology to deactivate specific disease-causing genes safely and effectively, using non-pathogenic bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut Pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/Harvard Medical School. A privately held company based in Cambridge, Massachusetts, Cequent was established in 2006. In July 2010, Cequent Pharmaceuticals was acquired by Marina Biotech, Inc (formerly MDRNA, Inc) for $46M.
CRI Lifetree operates as a specialized research organization. The Company focuses on the conduct and design of early stage endocrinology and infectious disease research products and services. CRI Lifetree provides clinical research throughout the United States.
Magellan Diagnostics, Inc., a medical device company, develops and manufactures point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing. Its products include LeadCare II, a blood lead testing system; LeadCare Ultra, which provides blood lead results for laboratories; and LeadCare Plus, a solution for laboratories with smaller volumes for performing lead testing in house. The company also provides various analytical services, such as lead and heavy metal exposure, monitoring exposure in employees, and testing. It offers solutions for clinicians, public health providers, managed care organizations, and families and communities. Magellan Diagnostics, Inc. was formerly known as Magellan Biosciences, Inc. The company was founded in 2004 and is headquartered in North Billerica, Massachusetts. Magellan Diagnostics, Inc. operates as a subsidiary of Magellan Biosciences, Inc.
FirstRain, Inc. develops a business analytics platform that assists Fortune 1000 companies in building their strategies, creating lead generation campaigns, discovering and developing new sales opportunities, and identifying business risks. The company was founded in 2000 and is headquartered in San Mateo, California. As of July 31, 2017, FirstRain, Inc. operates as a subsidiary of Ignite Technologies, Inc.
Ortho Organizers
Seed Round in 2006
Ortho Organizers, a full-line manufacturer and distributor of orthodontics products.
RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.
Assay Designs
Series A in 2005
Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.
Medifacts International
Series A in 2005
As of February 5, 2010, Medifacts International, Inc. was acquired by CoreLab Partners. Medifacts International, Inc. provides cardiovascular safety monitoring services to the pharmaceutical and biotech industry. The company offers electrocardiogram (ECG) services, digital Holter services, ambulatory blood pressure monitoring, automated blood pressure, telemedicine, and assessment of arterial stiffness in clinical trials, as well as glucose monitoring and pulmonary services. It also provides consulting and medical writing services, including expert program and protocol design, protocol development, expert interim reports, statistical analysis plans and reports, ECG analysis, regulatory guidance and support, expert summary reports for inclusion in the clinical study reports, and statistical analysis planning and biostatistics, as well as digital data collection, transmission, and analysis. The company was founded in 1985 and is headquartered in Rockville, Maryland with additional offices in Langenfeld, Germany; and Shanghai, China.
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.
ESA Bioscience
Acquisition in 2004
ESA Bioscience is a company that was acquired by Ampersand Capital Partners in 2004.
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The companys discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
Proficiency, Inc. provides product knowledge integration and CAD interoperability solutions that enable manufacturers and suppliers to share product knowledge from various engineering and manufacturing environments. Its solutions include product knowledge migration, which delivers a process of technology and methodology that meets migration needs; and supplier delivery solutions to original equipment manufacturers or higher tier suppliers. The company’s products also include Collaboration Gateway V7.0, which enables the transfer of the product knowledge between CAD systems that include geometry, features, sketches, manufacturing info, metadata, assembly information, and drawings in the conversion process; and Completion Wizard, which provides an interactive method of completing the process. In addition, it offers CAD translation services, such as geometry-only, product knowledge, and associative drawing translations; consulting services, such as migration strategy, supplier delivery strategy, and process integration consulting; and implementation services, such as training, customer support, and customer specific developments. The company serves various companies in the automotive, aerospace and defense, and heavy machinery industries. Proficiency, Inc. was founded in 1998 and is based in Marlborough, Massachusetts. As of July 1, 2009, Proficiency, Inc. operates as a subsidiary of ITI TranscenData.
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.
FirstRain, Inc. develops a business analytics platform that assists Fortune 1000 companies in building their strategies, creating lead generation campaigns, discovering and developing new sales opportunities, and identifying business risks. The company was founded in 2000 and is headquartered in San Mateo, California. As of July 31, 2017, FirstRain, Inc. operates as a subsidiary of Ignite Technologies, Inc.
Viadux is a prominent provider of in-building broadband access solutions tailored for the telecommunications and cable sectors. The company collaborates with service providers to facilitate the delivery of high-speed data, video, and voice services to small-to-medium enterprises and residential customers, particularly within the Multi-Tenant Unit (MTU/MDU) market. Based in Australia, Viadux operates as a subsidiary of Reece Limited and has a history of involvement in steel water pipes and fittings, reflecting its diverse operational background.
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.
Ensemble Communications
Venture Round in 2002
Ensemble Communications develops wireless infrastructure equipment for high-speed local broadband access applications.
Cyclis Pharmaceuticals
Series A in 2002
Cyclis is researching and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.
Endeca is a provider of information management software that focuses on enterprise search solutions for large organizations. The company serves notable clients, including Borders, Boeing, and the Census Bureau, by offering guided search capabilities that auto-categorize results based on user-entered keywords. This functionality enables organizations to make informed decisions based on evolving business needs and data integration requirements. Endeca's pricing model ranges from $100,000 to over $10 million per installation, reflecting the scale and complexity of the services provided. The company competes in the market with other search technology providers, such as FAST Search & Transfer.
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.
Blackstone Technology Group provides software and services that create high throughput computing environments. Blackstone helps customers speed time-to-market by designing and optimizing infrastructures for high user productivity, low administrative burden, and low ownership cost. Blackstone accomplishes these goals with Consultants who have expertise in the applications and process methodologies, as well as in the design and optimization of large-scale, high-throughput computing environments; and Software products that simplify usage and administration of the environment, as well as maximize computing throughput and architecture scalability.
LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.